Press release
Overview of Peptide Based Cardiovascular Therapeutics Market: Size, Trends, Share and Growth Forecast till 2022
Fact.MR
Request for Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=191
Cardiovascular disease is the leading cause of mortality and morbidity all over the world. In the past, the development of peptides as therapeutic agents had been avoided by pharmaceutical industry due to their low stability, rate of degradation and poor delivery. However, in recent times, resurgence has taken place in the field of peptides as therapeutics. Economic factors such as increasing healthcare expenditure and increasing FDI in emerging economies are expected to drive the market of peptide based cardiovascular therapeutics. Additionally, increasing prevalence of cardiovascular disorders, emergence of prominent pharmaceutical and biotech companies and strong R&D in the development of new peptides are fuelling the market growth. However, various factors such as increasing costs of commercialization, rapid metabolism of peptide drugs and regulatory conditions are expected to hamper market growth.
This Fact.MR report on the global peptide based cardiovascular therapeutics market forecasts that the global peptide based cardiovascular therapeutics market will touch a value of nearly US$ 1,960 Mn in the year 2022 and grow at a robust CAGR during the assessment period.
3 Forecast Highlights on Global Peptide Based Cardiovascular Therapeutics Market
1. As per the forecast of Fact.MR, the eptifibatide segment is slated to touch a value of nearly US$ 600 Mn in the year 2022. This represents a robust CAGR growth during the assessment period of 2017-2022. The eptifibatide segment is estimated to account for nearly one-third of the revenue share of the drug segment by the year 2017 end and is expected to gain in market share by the year 2022 end.
2. As per the forecast of Fact.MR, the retail pharmacies segment will reach a value of nearly US$ 425 Mn in the year 2017. This represents a robust CAGR growth during the forecast period. The retail pharmacies segment is estimated to account for more than one-third of the revenue share of the distribution channel segment in the year 2017 end and is expected to gain market share by the end of the year 2022.
3. As per the forecast of Fact.MR, North America peptide based cardiovascular therapeutics market is expected to register a robust CAGR over the forecast period and to be valued at nearly US$ 830 Mn by 2022 end.
Browse Full Report with TOC- https://www.factmr.com/report/191/peptide-based-cardiovascular-therapeutics-market
Hospital Pharmacies Segment to exhibit a CAGR of 8.9% During the Assessment Period
As per the forecast of Fact.MR, the hospital pharmacies segment is slated to touch a figure of nearly US$ 960 Mn in the year 2022. This represents a CAGR of 8.9% during the assessment period from 2017 till the year 2022. This segment is expected to lose market share by the end of the year 2022. The hospital pharmacies segment is expected to account for more than half of the revenue share of the distribution channel segment by the year 2017.
Bivalirudin Segment Poised to Touch a Value of Nearly US$ 1,360 Mn in 2022
As per the forecast of Fact.MR, the bivalirudin segment is expected to reach a value of nearly US$ 1,360 Mn in the year 2022. This represents a robust CAGR during the forecast period of 2017-2022. Bivalirudin segment is expected to account for more than two-third of the revenue share of the drug segment by the year 2017 and is expected to lose market share by the end of the year 2022.
Table of Contents:
1. Global Peptide Based Cardiovascular Therapeutics Market – Executive Summary
2. Global Peptide Based Cardiovascular Therapeutics Market Overview
2.1. Introduction
2.1.1. Global Peptide Based Cardiovascular Therapeutics Market Taxonomy
2.1.2. Global Peptide Based Cardiovascular Therapeutics Market Definition
2.2. Global Peptide Based Cardiovascular Therapeutics Market Size (US$ Mn) and Forecast, 2012-2022
2.2.1. Global Peptide Based Cardiovascular Therapeutics Market Y-o-Y Growth
2.3. Global Peptide Based Cardiovascular Therapeutics Market Dynamics
2.4. Regulations
2.5. Supply Chain
2.6. Cost Structure
3. Global Peptide Based Cardiovascular Therapeutics Market Analysis and Forecast By Drug
3.1. Global Peptide Based Cardiovascular Therapeutics Market Size and Forecast By Drug, 2012-2022
3.1.1. Bivalirudin Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
3.1.1.1. Revenue (US$ Mn) Comparison, By Region
3.1.1.2. Market Share Comparison, By Region
3.1.1.3. Y-o-Y growth Comparison, By Region
3.1.2. Eptifibatide Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
Continued……….
Request Methodology of the Report- https://www.factmr.com/connectus/sample?flag=RM&rep_id=191
About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized Healthcare market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
Fact.MR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Telephone: +353-1-6111-593
Email: sales@factmr.com
Web: https://www.factmr.com/
Follow us in Linkedin: https://www.linkedin.com/company/factmr/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Overview of Peptide Based Cardiovascular Therapeutics Market: Size, Trends, Share and Growth Forecast till 2022 here
News-ID: 1073012 • Views: …
More Releases from Fact.MR
Cheese Market Is Anticipated To Reach US$ 133 Billion At A CAGR Of 3.7% By 2032: …
In 2022, the global cheese market held a value of US$ 92 billion, with projections indicating a substantial growth trajectory. By the end of 2032, it is anticipated to soar to US$ 133 billion, according to a study conducted by Fact.MR. The research suggests that the worldwide demand for cheese is expected to experience a steady increase, with a compound annual growth rate (CAGR) of 3.7% forecasted through the year…
Product Engineering Services Market Is Set To Reach A Valuation Of US$ 2,400 Bil …
As of 2023, the global market for product engineering services reached a valuation of US$ 1,200 billion, with a projected growth to US$ 2,400 billion by the end of 2033. Forecasts indicate a steady increase in global demand for these services, with a compound annual growth rate (CAGR) expected to reach 7.2% from 2023 to 2033.
The Product Engineering Services Industry sales study offers a comprehensive analysis on diverse features including…
Golf Shoes Market Is Anticipated To Reach US$ 13,331.7 Million By 2032: Fact.MR …
In 2022, the worldwide golf shoes market is projected to be valued at US$ 8,584.1 million. It's anticipated to grow steadily at a compound annual growth rate (CAGR) of 4.4%, reaching US$ 13,331.7 million by 2032.
The Golf Shoes Industry sales study offers a comprehensive analysis on diverse features including production capacities, Golf Shoes demand, product developments, sales revenue generation and Golf Shoes market outlook across the globe.
market research report by…
Home Entertainment Devices Market Forecasted to Achieve US$ 450 Billion by 2033, …
The home entertainment devices market is projected to grow from its 2023 valuation of US$ 250 billion to US$ 450 billion by 2033. Between 2023 and 2033, home entertainment device sales are expected to grow globally at a compound annual growth rate (CAGR) of 6%.
These days, consumers may order their home entertainment systems online while lounging at home, working from the office, or from anywhere else. Online platforms are widely…
More Releases for Cardiovascular
Increasing Prevalence of Cardiovascular Diseases to Augment the Cardiovascular I …
Cardiovascular information system offers on-time access to cardiovascular electronic medical records in reports, images, and waveforms, and allows easy report generation and distribution. Cardiovascular information system is extensively used in electrocardiography (ECG) data management, echocardiography, catheterization, and vascular solutions.
Click Here To Get Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/20
Cardiovascular information system is used to store, archive, and share healthcare information. It is a unique software solution that helps improve the clinical and financial…
Global Cardiovascular Drugs Market
Global Cardiovascular Drugs Market – Industry Analysis and Forecast (2018-2026) – by Drug Class, Indications, Distribution Channels, and Region.
Global Cardiovascular Drugs Market was valued at US$ 80.5 Bn in 2017 and is expected to reach US$ 98.8 Bn by 2026, at a CAGR of 2.6 % during the forecast period.
The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data,…
Mexico Cardiovascular Devices Market Outlook to 2025 Cardiac Assist Devices, Car …
Orbisresearch.com has announced the addition of Mexico Cardiovascular Devices Market. The report focuses on global major leading industry players with information such as company profiles, product picture and specification.
Mexico Cardiovascular Devices Market Outlook to 2025, provides key market data on the Mexico Cardiovascular Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market categories - Cardiac Assist Devices, Cardiac Rhythm…
Cardiovascular Drugs Market | Insights
Some of the common cardiovascular diseases include hypertensive heart disease, rheumatic heart disease, ischemic heart disease, inflammatory heart disease, and cerebrovascular heart disease. Major problems associated with hypertensive heart disease include angina, hypertrophy, and heart failure. These problems are caused due to high blood pressure in the heart’s arteries and muscles, which causes narrowing of arteries and thickening and enlargement of heart. The global cardiovascular drug market is primarily driven…
Increasing Cardiovascular Surgeries Leads To Higher Market Value For Cardiovascu …
When a coronary artery is narrowed by the accumulation of fatty acids, also known as plaque, the blood flow to heart is reduced which result in the chest pain and if the blockage increases the blood flow to the heart is further reduced and might lead to cardiac arrest. To reduce the chances of heart attack, a tiny wire mesh tube is inserted in the artery with a balloon catheter,…
Cardiovascular Monitoring and Diagnostic Devices Market to be Driven with the Ri …
The global market for cardiovascular monitoring and diagnostic devices is expected to expand at a healthy CAGR of 6.4% over the period between 2016 and 2024, rising from a valuation of US$1.8 bn in 2015 to US$3.1 bn by 2024. The segment of ECG systems contributed the largest share to the market’s overall revenues in 2015, accounting for nearly US$878 mn in 2015. However, the segment of implantable loop recorder…
